Upstream Bio, Inc.
UPB
$6.75
$0.396.13%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -48.85% | -99.88% | -111.03% | -172.29% | -150.32% |
| Total Depreciation and Amortization | 13.95% | 16.33% | 228.57% | 223.08% | 230.77% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 291.10% | 38.81% | 98.85% | 499.32% | 136.69% |
| Change in Net Operating Assets | 24.17% | 687.78% | 1,138.35% | -116.81% | -287.57% |
| Cash from Operations | -16.24% | -56.18% | -59.29% | -388.29% | -134.40% |
| Capital Expenditure | -- | 70.81% | 80.37% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 119.87% | 40.16% | 2,680.98% | 110.99% | -1,640.43% |
| Cash from Investing | 119.87% | 40.65% | 3,319.87% | 110.95% | -1,640.43% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -99.60% | 3,900.00% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | 100.00% | 100.00% | -- |
| Cash from Financing | 1,858.82% | -99.59% | 146.31% | -99.56% | -100.36% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 98.09% | -89.96% | 288.15% | -263.36% | -4,584.41% |